Aktis Oncology Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Aktis Oncology stock has a consensus rating of "Strong Buy" and an average price target of $33.88. The average 1-year stock price forecast is 15.08% higher than the current stock price, while the lowest is $30 (+1.90%) and the highest is $40 (+35.87%).

Price Target: $33.88 (+15.08%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$33.88	$33.5	$40
Change	+1.90%	+15.08%	+13.79%	+35.87%

Analyst Ratings

The average analyst rating for Aktis Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	4	5	5	6
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	4	5	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christopher Raymond Raymond James	Raymond James	Buy Initiates $40	Buy	Initiates	$40	+35.87%	Jun 15, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $35	Buy	Reiterates	$35	+18.89%	Jun 2, 2026
Alexandra Ramsey William Blair	William Blair	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Jun 1, 2026
Alec Stranahan Bank of America Securities	Bank of America Securities	Buy Maintains $34	Buy	Maintains	$34	+15.49%	Jun 1, 2026
Tyler Van Buren TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

10.58M

from 6.50M

62.78%

from 6.50M

Revenue Next Year

11.55M

from 10.58M

9.21%

from 10.58M

EPS This Year

-1.60

from -78.34

EPS Next Year

-1.94

from -1.60

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	1.49M	6.50M	10.58M
Revenue Growth	-	-	-	336.92%	62.78%
Gross Profit	-	-25.92M	-39.47M	-60.95M	10.58M
Gross Margin	-	-	-2,654.14%	-938.19%	100.00%
Operating Income	-19.76M	-34.79M	-52.05M	-74.68M	-114.78M
Net Income	-17.93M	-28.64M	-43.98M	-63.73M	-84.64M
EPS	-	-	-	-78.34	-1.60
Free Cash Flow	-	-21.08M	-20.08M	-36.24M	-87.00M
No. Analysts	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	21.8M
Avg	10.6M
Low	3.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	235.5%
Avg	62.8%
Low	-50.3%

EPS Forecast

EPS	2026	2027	2028
High	-1.12
Avg	-1.60
Low	-2.08

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-